SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)

NCT02342600 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Supporting company withdrew interest

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Pazopanib
DRUG: Trametinib

Sponsor

Sarcoma Alliance for Research through Collaboration

Collaborators

[object Object]